Addressing Clinicians’ Challenges and Misinformation Around New and Emerging Treatments for Alzheimer Disease episode artwork

EPISODE · Sep 20, 2022 · 11 MIN

Addressing Clinicians’ Challenges and Misinformation Around New and Emerging Treatments for Alzheimer Disease

from Pri-Med Podcasts · host Pri-Med

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/alzheimer-disease-addressing-challenges-pt2 Overview: Alzheimer disease (AD) treatment is evolving. With this rapid expansion in potential therapies, there remain challenges and misconceptions. Join neurologist Gad Marshall, MD in this two-part podcast series, as he answers important questions about new and emerging disease-modifying therapies and explores ways in which these treatments may be considered in the future for patients.  The topics covered in this podcast are based on challenges and misconceptions identified from the CME/CE curriculum The Future of Alzheimer Disease: Early Recognition and Emerging Therapy.

Episode metadata supplied by the publisher feed · Published Sep 20, 2022

Embed this episode

Ready to play

Addressing Clinicians’ Challenges and Misinformation Around New and Emerging Treatments for Alzheimer Disease

0:00 11:38

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Pri-Med Podcasts?

This episode is 11 minutes long.

When was this Pri-Med Podcasts episode published?

This episode was published on September 20, 2022.

Can I download this Pri-Med Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!